• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    QUAKER HOUGHTON ANNOUNCES SECOND QUARTER 2025 RESULTS

    7/31/25 4:30:00 PM ET
    $KWR
    Major Chemicals
    Industrials
    Get the next $KWR alert in real time by email
    • Q2'25 net sales of $483.4 million, an increase of 4% Y/Y
    • Organic sales volumes increased 2% Y/Y driven by new business wins of approximately 5%
    • Q2'25 net loss of $66.6 million and loss per diluted share of $3.78, which includes an $88.8 million impairment charge
    • Q2'25 non-GAAP net income of $30.0 million and non-GAAP earnings per diluted share of $1.71
    • Delivered adjusted EBITDA and adjusted EBITDA margins of $75.5 million and 15.6%, respectively, in Q2'25
    • Share repurchases totaled $32.7 million in Q2'25 and the Company raised its quarterly cash dividend by approximately 5%

    CONSHOHOCKEN, Pa., July 31, 2025 /PRNewswire/ -- Quaker Houghton ("the Company") (NYSE:KWR), the global leader in industrial process fluids, announced its second quarter 2025 results today. 



    Three Months Ended

    June 30,



    Six Months Ended

    June 30,

    ($ in thousands, except per share data)

    2025



    2024



    2025



    2024

    Net sales

    $           483,400



    $           463,567



    $         926,314



    $         933,326

    Net (loss) income attributable to Quaker Chemical Corporation

    (66,580)



    34,885



    (53,658)



    70,112

    Net (loss) income attributable to Quaker Chemical Corporation

    common shareholders – diluted

    (3.78)



    1.94



    (3.04)



    3.89

    Non-GAAP net income *

    30,000



    38,232



    58,029



    75,905

    Non-GAAP Earnings per diluted share *

    1.71



    2.13



    3.29



    4.22

    Adjusted EBITDA *

    75,479



    84,291



    144,527



    167,573



    *   Refer to the Non-GAAP Measures and Reconciliations section below for additional information

    Second Quarter 2025 Consolidated Results

    Net sales in the second quarter of 2025 were $483.4 million, an increase of 4% compared to $463.6 million in the second quarter of 2024.  This increase was primarily driven by an increase in sales volumes of 2% and a contribution from acquisitions of approximately 6%, partially offset by a decline in selling price and product mix of approximately 4%.  The increase in sales volumes compared to the prior year was primarily a result of continued growth in the Asia/Pacific segment and approximately 5% growth from new business wins, which more than offset a continuation of soft end market conditions including the impact from uncertainty caused by tariffs, particularly in the Americas and EMEA segments.  The decrease in selling price and product mix was primarily attributable to the impact of the mix of products, services and geographies and the impact of our index-based customer contracts.  Organic sales volumes increased 4% compared to the first quarter of 2025.

    The Company reported a net loss in the second quarter of 2025 of $66.6 million, or $3.78 per diluted share, compared to net income of $34.9 million, or $1.94 per diluted share, in the second quarter of 2024.  The Company's reported net loss primarily reflects an $88.8 million non-cash goodwill impairment charge associated with the Company's EMEA reportable segment. Excluding non-recurring and non-core items in each period, the Company's non-GAAP net income and non-GAAP earnings per diluted share were $30.0 million and $1.71 respectively in the second quarter of 2025 compared to $38.2 million and $2.13 respectively in the second quarter of the prior year.  The Company generated adjusted EBITDA of $75.5 million in the second quarter of 2025, a decrease of approximately 10% compared to $84.3 million in the second quarter of 2024, as the increase in net sales was offset by lower operating margins. See the Non-GAAP Measures and Reconciliations section below for additional information.

    Joe Berquist, Chief Executive Officer and President, commented, "Quaker Houghton executed well in the second quarter of 2025.  We generated 2% year-over-year organic volume growth in the quarter, delivering above market growth due to strong new business wins across all segments.  The momentum in our Asia/Pacific segment continued, generating 8% organic volume growth compared to the prior year.  I am proud of how the team adapted to the challenging macroeconomic environment, particularly in the U.S. and Europe, while maintaining a clear focus on our customers.  We also made progress in the quarter advancing our enterprise strategy while effectively managing costs.

    "Economic conditions are likely to remain tepid in the second half of 2025.  While this challenging environment of uncertainty persists, we have meaningful opportunities across our portfolio to gain profitable new business. We have also initiated actions that we expect will deliver approximately $20 million of additional run-rate cost savings by the end of 2026.  We expect to achieve a stronger performance from our business in the second half, positioning us to deliver full year 2025 revenue and earnings in the range of 2024.  Our strong balance sheet and consistent cash flow generation will enable us to continue to execute the capital allocation levers at our disposal and create value for shareholders."

    Second Quarter 2025 Segment Results

    The Company's second quarter and the first six months of 2025 operating performance for each of its three reportable segments: (i) Americas; (ii) EMEA; and (iii) Asia/Pacific, is further described below. 



    Three Months Ended

    June 30,



    Six Months Ended

    June 30,



    2025



    2024



    2025



    2024

    Net Sales *















    Americas

    $         221,062



    $         223,517



    $         434,773



    $         453,271

    EMEA

    139,923



    138,001



    269,201



    276,423

    Asia/Pacific

    122,415



    102,049



    222,340



    203,632

    Total net sales

    $         483,400



    $         463,567



    $         926,314



    $         933,326

    Segment operating earnings *















    Americas

    $           58,976



    $           64,137



    $         117,438



    $         130,906

    EMEA

    24,995



    26,652



    48,388



    56,223

    Asia/Pacific

    28,715



    31,000



    54,645



    61,377

    Total segment operating earnings

    $         112,686



    $         121,789



    $         220,471



    $         248,506



    *   Refer to the Segment Measures and Reconciliations section below for additional information

    The following table summarizes the sales variances by reportable segment and consolidated operations in the second quarter of 2025 compared to the second quarter of 2024:



    Sales volumes



    Selling price &

    product mix



    Foreign

    currency



    Acquisition &

    other



    Total

    Americas

    (2) %



    1 %



    (2) %



    2 %



    (1) %

    EMEA

    1 %



    (7) %



    4 %



    3 %



    1 %

    Asia/Pacific

    8 %



    (5) %



    — %



    17 %



    20 %

    Consolidated

    2 %



    (4) %



    — %



    6 %



    4 %

    Net sales in the Asia/Pacific segment increased 20% in the second quarter of 2025 compared to the same period in 2024, as an increase in sales volumes and a further contribution in sales from acquisitions, primarily Dipsol and Sutai, was partially offset by a decrease in selling price and product mix.  Net sales in the EMEA segment increased approximately 1% in the second quarter of 2025 compared to the same period in 2024, due to an increase in sales volumes, a further increase in sales from acquisitions, and a favorable impact of foreign currency translation, partially offset by a decline in selling price and product mix.  Net sales in the Americas segment declined approximately 1% in the second quarter of 2025 compared to the same period in 2024, primarily due to a decrease in sales volumes and an unfavorable impact of foreign currency translation, partially offset by a modest increase in selling price and product mix and a contribution in sales from acquisitions.

    Underlying end market activity in the second quarter of 2025 remained below prior year levels, amplified by uncertainty related to tariffs, especially in the Americas and EMEA segments, while end market activity in Asia/Pacific improved.  New business wins were strong across all segments.  The decline in selling price and product mix in the second quarter of 2025 compared to the same period in 2024 reflects changes in the mix of products, services and geographies, and the impact of our index-based customer contracts.

    Consolidated net sales increased approximately 9% compared to the first quarter of 2025, driven by an increase in organic sales volumes, a further contribution from acquisitions, and a favorable impact from foreign currency translation, partially offset by a decline in selling price and product mix.  Net sales and sales volumes increased in all segments compared to the first quarter of 2025 driven by new business wins, despite a continuation of soft underlying end market activity, whereas selling price and product mix declined.  Acquisitions and foreign currency translation was favorable to sales across all segments in the second quarter of 2025 compared to the first quarter of 2025.

    Operating earnings decreased in all segments in the second quarter of 2025 compared to the prior year, primarily due to lower segment operating margins as a result of higher raw material and manufacturing costs and SG&A expenses. Segment operating earnings increased in all segments in the second quarter of 2025 compared to the first quarter of 2025, primarily driven by an increase in net sales.

    Cash Flow and Liquidity Highlights

    Net cash provided by operating activities was $38.5 million for the six months ended June 30, 2025, compared to $73.5 million for the same period in 2024. The Company's operating cash flow reflects lower operating performance and higher cash outflows from restructuring activities, partially offset by a modest improvement in working capital management.

    As of June 30, 2025, the Company's total gross debt was $936.7 million and its cash and cash equivalents was $201.9 million, which resulted in net debt of approximately $734.8 million. The Company's net debt divided by its trailing twelve months adjusted EBITDA was approximately 2.6x, primarily reflecting the acquisition of Dipsol, which was completed in April 2025 and was funded with borrowings under the Company's existing credit facility. In the second quarter of 2025, the Company repurchased 296,113 shares for $32.7 million.

    Non-GAAP Measures and Reconciliations

    The information in this press release includes non-GAAP (unaudited) financial information that includes EBITDA, adjusted EBITDA, adjusted EBITDA margin, non-GAAP operating income, non-GAAP operating margin, non-GAAP gross profit, non-GAAP gross margin, taxes on income before equity in net income of associated companies – adjusted, non-GAAP net income and non-GAAP earnings per diluted share. The Company believes these non-GAAP financial measures provide meaningful supplemental information as they enhance a reader's understanding of the financial performance of the Company, facilitate a comparison among fiscal periods, and exclude items that management believes are not indicative of future operating performance or considered core to the Company's operations.  Non-GAAP results are presented for supplemental informational purposes only and should not be considered a substitute for the financial information presented in accordance with GAAP. In addition, our definitions of EBITDA, adjusted EBITDA, adjusted EBITDA margin, non-GAAP operating income, non-GAAP operating margin, non-GAAP gross profit, non-GAAP gross margin,  taxes on income before equity in net income of associated companies – adjusted, non-GAAP net income, and non-GAAP earnings per diluted share, as discussed and reconciled below to the most comparable GAAP measures, may not be comparable to similarly named measures reported by other companies. 

    The Company presents EBITDA, which is calculated as net income attributable to the Company before depreciation and amortization, interest expense, and taxes on income before equity in net income of associated companies.  The Company also presents adjusted EBITDA, which is calculated as EBITDA plus or minus certain items that management believes are not indicative of future operating performance or considered core to the Company's operations. In addition, the Company presents non-GAAP operating income, which is calculated as operating income plus or minus certain items that management believes are not indicative of future operating performance or considered core to the Company's operations. Additionally, the Company presents non-GAAP gross profit, which is calculated as gross profit plus or minus certain items that management believes are not indicative of future operating performance or considered core to the Company's operations. In addition, the Company presents non-GAAP Adjusted EBITDA margin, non-GAAP operating margin, and non-GAAP gross margin, which are calculated as the percentage of adjusted EBITDA, non-GAAP operating income, and non-GAAP gross profit to consolidated net sales, respectively. The Company believes these non-GAAP measures provide transparent and useful information and are widely used by analysts, investors, and competitors in our industry as well as by management in assessing the operating performance of the Company on a consistent basis.

    Additionally, the Company presents non-GAAP net income and non-GAAP earnings per diluted share as additional performance measures. Non-GAAP net income is calculated as adjusted EBITDA, defined above, less depreciation and amortization, interest expense, and taxes on income before equity in net income of associated companies, in each case adjusted, as applicable, for any depreciation, amortization, interest or tax impacts resulting from the non-core items identified in the reconciliation of net income attributable to the Company to adjusted EBITDA. Non-GAAP earnings per diluted share is calculated as non-GAAP net income per diluted share as accounted for under the "two-class share method." The Company believes that non-GAAP net income and non-GAAP earnings per diluted share provide transparent and useful information and are widely used by analysts, investors, and competitors in our industry as well as by management in assessing the performance of the Company on a consistent basis.

    As it relates to future projections for the Company as well as other forward-looking information contained in this press release, the Company has not provided guidance for comparable GAAP measures or a quantitative reconciliation of forward-looking non-GAAP financial measures to the most directly comparable U.S. GAAP measure because it is unable to determine with reasonable certainty the ultimate outcome of certain significant items necessary to calculate such measures without unreasonable effort.  These items include, but are not limited to, certain non-recurring or non-core items the Company may record that could materially impact net income.  These items are uncertain, depend on various factors, and could have a material impact on the U.S. GAAP reported results for the guidance period. 

    The Company's reference to trailing twelve months adjusted EBITDA within this press release refers to the twelve month period ended June 30, 2025 adjusted EBITDA of $287.8 million, which consists of (i) the six months ended June 30, 2025 adjusted EBITDA of $144.5 million, as presented in the non-GAAP reconciliations below, and (ii) the twelve months ended December 31, 2024 adjusted EBITDA of $310.9 million, as presented in the non-GAAP reconciliations included in the Company's fourth quarter and full year 2024 results press release dated February 24, 2025, less (iii) the six months ended June 30, 2024 adjusted EBITDA of $167.6 million, as presented in the non-GAAP reconciliations below. 

    Certain of the prior period non-GAAP financial measures presented in the following tables have been adjusted to conform with current period presentation.  The following tables reconcile the Company's non-GAAP financial measures (unaudited) to their most directly comparable GAAP (unaudited) financial measures (dollars in thousands unless otherwise noted, except per share amounts):

    Non-GAAP Gross Profit and Margin Reconciliations

    Three Months Ended

    June 30,



    Six Months Ended

    June 30,



    2025



    2024



    2025



    2024

    Gross profit

    $      171,723



    $      175,718



    $      332,983



    $      357,281

    Acquisition-related step-up inventory amortization

    6,022



    —



    6,022



    —

    Gain on inventory and other adjustments

    (3,604)



    —



    (3,604)



    —

    Non-GAAP gross profit

    $      174,141



    $      175,718



    $      335,401



    $      357,281

    Non-GAAP profit margin (%)

    36.0 %



    37.9 %



    36.2 %



    38.3 %

     

    Non-GAAP Operating Income and Margin Reconciliations

    Three Months Ended

    June 30,



    Six Months Ended

    June 30,



    2025



    2024



    2025



    2024

    Operating (loss) income

    $      (52,510)



    $        58,449



    $       (24,886)



    $       113,975

    Acquisition-related step-up inventory amortization

    6,022



    —



    6,022



    —

    Restructuring and related charges, net

    8,793



    320



    23,383



    2,177

    Acquisition-related expenses

    803



    234



    4,133



    517

    Gain on inventory and other adjustments

    (3,927)



    —



    (3,927)



    —

    Customer insolvency costs

    —



    —



    —



    1,522

    Impairment charges

    88,840



    —



    88,840



    —

    Acquisition-related depreciation and amortization

    1,681



    —



    1,681



    —

    Other charges

    939



    812



    1,165



    866

    Non-GAAP operating income

    $        50,641



    $        59,815



    $         96,411



    $       119,057

    Non-GAAP operating margin (%)

    10.5 %



    12.9 %



    10.4 %



    12.8 %

     

    EBITDA, Adjusted EBITDA, Adjusted EBITDA Margin and Non-GAAP Net Income Reconciliations

    Three Months Ended

    June 30,



    Six Months Ended

    June 30,

    2025



    2024



    2025



    2024

    Net (loss) income attributable to Quaker Chemical Corporation

    $      (66,580)



    $        34,885



    $       (53,658)



    $         70,112

    Depreciation and amortization (a)

    23,921



    21,428



    44,751



    42,484

    Interest expense

    12,779



    10,754



    22,324



    21,578

    Taxes on income before equity in net income of associated companies (b)

    5,472



    15,778



    13,014



    28,286

    EBITDA

    (24,408)



    82,845



    26,431



    162,460

    Equity income in a captive insurance company

    (2,075)



    (475)



    (2,746)



    (981)

    Acquisition-related step-up inventory amortization

    6,022



    —



    6,022



    —

    Restructuring and related charges, net

    8,793



    320



    23,383



    2,177

    Acquisition-related expenses

    803



    234



    4,133



    517

    Gain on inventory and other adjustments

    (3,927)



    —



    (3,927)



    —

    Customer insolvency costs

    —



    —



    —



    1,522

    Impairment charges

    88,840



    —



    88,840



    —

    Product liability claim costs, net

    —



    —



    —



    896

    Currency conversion impacts of hyper-inflationary economies

    652



    613



    1,187



    (291)

    (Gain) loss on acquisition-related hedges

    (592)



    —



    1,351



    —

    Gain on sale of assets

    (357)



    —



    (2,534)



    —

    Other charges

    1,728



    754



    2,387



    1,273

    Adjusted EBITDA

    $        75,479



    $        84,291



    $       144,527



    $       167,573

    Adjusted EBITDA margin (%)

    15.6 %



    18.2 %



    15.6 %



    18.0 %

















    Adjusted EBITDA

    $        75,479



    $        84,291



    $       144,527



    $       167,573

    Less: Depreciation and amortization (a)

    23,921



    21,428



    44,751



    42,484

    Less: Interest expense

    12,779



    10,754



    22,324



    21,578

    Less: Taxes on income before equity in net income of associated companies - adjusted (b)

    10,460



    13,877



    21,104



    27,606

    Plus: Acquisition-related depreciation and amortization

    1,681



    —



    1,681



    —

    Non-GAAP net income

    $        30,000



    $        38,232



    $         58,029



    $         75,905

     



    Three Months Ended

    June 30,



    Six Months Ended

    June 30,

    Non-GAAP Earnings per Diluted Share Reconciliations

    2025



    2024



    2025



    2024

    GAAP (loss) earnings per diluted share attributable to Quaker Chemical Corporation common shareholders

    $              (3.78)



    $                1.94



    $               (3.04)



    $                3.89

    Equity income in a captive insurance company

    (0.12)



    (0.02)



    (0.16)



    (0.05)

    Acquisition-related step-up inventory amortization

    0.25



    —



    0.25



    —

    Restructuring and related charges, net

    0.38



    0.01



    1.00



    0.09

    Acquisition-related expenses

    0.05



    0.01



    0.19



    0.02

    Gain on inventory and other adjustments

    (0.16)



    —



    (0.16)



    —

    Customer insolvency costs

    —



    —



    —



    0.06

    Impairment charges

    4.91



    —



    4.91



    —

    Product liability claim costs, net

    —



    —



    —



    0.04

    Currency conversion impacts of hyper-inflationary economies

    0.04



    0.03



    0.07



    (0.02)

    (Gain) loss on acquisition-related hedges

    (0.02)



    —



    0.06



    —

    Gain on sale of assets

    (0.02)



    —



    (0.11)



    —

    Other charges

    0.06



    0.03



    0.08



    0.06

    Discrete tax items

    0.05



    0.13



    0.13



    0.13

    Acquisition-related depreciation and amortization

    0.07



    —



    0.07



    —

    Non-GAAP earnings per diluted share

    $                1.71



    $                2.13



    $                3.29



    $                4.22





    a.

    Depreciation and amortization for the three and six months ended June 30, 2025 and 2024 each includes approximately $0.2 million and $0.5 million, respectively, of amortization expense recorded within equity in net income of associated companies in the Company's Condensed Consolidated Statements of Operations. This is attributable to the amortization of the fair value purchase accounting step-up in connection with the acquisition of the Company's 50% equity interest in Korea Houghton Corporation.





    b.

    Taxes on income before equity in net income of associated companies – adjusted includes the Company's tax expense adjusted for the impact of any current and deferred income tax expense (benefit), as applicable, of the reconciling items presented in the reconciliation of Net income attributable to Quaker Chemical Corporation to adjusted EBITDA, above, determined utilizing the applicable rates in the taxing jurisdictions in which these adjustments occurred, subject to deductibility. This caption also includes the impact of specific tax charges and benefits for the three and six months ended June 30, 2025 and 2024.

    Segment Measures and Reconciliations

    Segment operating earnings for each of the Company's reportable segments are comprised of the segment's net sales less directly related product costs and other operating expenses. Operating expenses not directly attributable to the net sales of each respective segment, such as certain corporate and administrative costs and restructuring charges, are not included in segment operating earnings. Other items not specifically identified with the Company's reportable segments include Interest expense and Other (expense) income, net. 

    The following table presents information about the performance of the Company's reportable segments (dollars in thousands):



    Three Months Ended

    June 30,



    Six Months Ended

    June 30,



    2025



    2024



    2025



    2024

    Net Sales















    Americas

    $         221,062



    $         223,517



    $         434,773



    $         453,271

    EMEA

    139,923



    138,001



    269,201



    $         276,423

    Asia/Pacific

    122,415



    102,049



    222,340



    $         203,632

    Total net sales

    $         483,400



    $         463,567



    $         926,314



    $         933,326

    Segment operating earnings















    Americas

    $           58,976



    $           64,137



    $         117,438



    $         130,906

    EMEA

    24,995



    26,652



    48,388



    $           56,223

    Asia/Pacific

    28,715



    31,000



    54,645



    $           61,377

    Total segment operating earnings

    112,686



    121,789



    220,471



    248,506

    Restructuring and related charges, net

    (8,793)



    (320)



    (23,383)



    (2,177)

    Impairment charges

    (88,840)



    —



    (88,840)



    —

    Non-operating and administrative expenses

    (50,860)



    (47,584)



    (101,577)



    (101,760)

    Depreciation of corporate assets and amortization

    (16,703)



    (15,436)



    (31,557)



    (30,594)

    Operating (loss) income

    (52,510)



    58,449



    (24,886)



    113,975

    Other (expense) income, net

    (653)



    422



    (1,362)



    1,502

    Interest expense

    (12,779)



    (10,754)



    (22,324)



    (21,578)

    (Loss) income before taxes and equity in net income of associated companies

    $          (65,942)



    $           48,117



    $          (48,572)



    $           93,899

    Forward-Looking Statements

    This press release contains "forward-looking statements" that fall under the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and the Securities Act of 1933, as amended.  These statements can be identified by the fact that they do not relate strictly to historical or current facts.  We have based these forward-looking statements on assumptions, projections and expectations about future events that we believe are reasonable based on currently available information, including statements regarding the potential effects of economic downturns; tariffs, including the uncertainty surrounding changes in tariffs; inflation and global supply chain constraints on the Company's business, results of operations, and financial condition; our expectation that we will maintain sufficient liquidity and remain in compliance with the terms of the Company's credit facility; expectations about future demand and raw material costs; and statements regarding the impact of increased raw material costs and pricing initiatives.  These forward-looking statements include statements with respect to our beliefs, plans, objectives, goals, expectations, anticipations, intentions, financial condition, results of operations, future performance, and business, which may differ materially from our actual results, including but not limited to the potential benefits of acquisitions and divestitures, the impacts on our business as a result of global supply chain constraints, and our current and future results and plans and statements that include the words "may," "could," "should," "would," "believe," "expect," "anticipate," "estimate," "intend," "outlook, "target", "possible", "potential", "plan" or similar expressions. Such statements include information relating to current and future business activities, operational matters, capital spending, and financing sources. A major risk is that demand for the Company's products and services is largely derived from the demand for our customers' products, which subjects the Company to uncertainties related to downturns in a customer's business and unanticipated customer production slowdowns and shutdowns.  Other major risks and uncertainties include, but are not limited to inflationary pressures, including increases in raw material costs; supply chain constraints and the impacts of economic downturns; customer financial instability; high interest rates and their impact on our and our customers' business operations; the impacts from acts of war, terrorism and military conflicts, including those in Ukraine and the Middle East as well as economic, political and governmental actions taken by various governments and governmental organizations in response; economic and political disruptions particularly in light of numerous elections globally and the possibility of regime changes; the possibility of economic recession; legislative and regulatory developments including changes to existing laws and regulations, or the way they are interpreted, applied or enforced; tariffs, retaliatory tariffs, "trade wars" and trade restrictions, and the economic and other sanctions imposed by other nations on Russia and Belarus and/or other government organizations; suspensions of activities in Russia by many multinational companies; foreign currency fluctuations; significant changes in applicable tax rates and regulations and the potential impacts therefrom, including those arising from H.R.1, commonly known as the "One Big Beautiful Bill Act"; future terrorist attacks and other acts of violence; the impacts of consolidation in our industry, including loss or consolidation of a major customer; the effects of climate change, fires or other natural disasters; the potential occurrence of cyber-security breaches, cyber-security attacks and other technology outages and security incidents; and U.S. political conditions and legislative and regulatory activity (or inactivity), including adoption of (or failure to adopt) new laws, regulations and executive orders, changes in existing laws, regulations and executive orders or the way they are interpreted or applied, and adoption of laws, regulations or executive orders that conflict among jurisdictions in which we operate. Furthermore, the Company is subject to the same business cycles as those experienced by our customers in the steel, automotive, aerospace, industrial equipment, aluminum and durable goods industries. Our forward-looking statements are subject to risks, uncertainties and assumptions about the Company and its operations that are subject to change based on various important factors, some of which are beyond our control.  These risks, uncertainties, and possible inaccurate assumptions relevant to our business could cause our actual results to differ materially from expected and historical results. All forward-looking statements included in this press release, including expectations about business conditions during 2025 and future periods, are based upon information available to the Company as of the date of this press release, which may change. Therefore, we caution you not to place undue reliance on our forward-looking statements. For more information regarding these risks and uncertainties as well as certain additional risks that we face, refer to the Risk Factors section, which appears in Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2024, and in subsequent reports filed from time to time with the Securities and Exchange Commission. We do not intend to, and we disclaim any duty or obligation to, update or revise any forward-looking statements to reflect new information or future events or for any other reason. This discussion is provided as permitted by the Private Securities Litigation Reform Act of 1995. 

    Conference Call

    As previously announced, the Company's investor conference call to discuss its second quarter of 2025 performance is scheduled for Friday, August 1, 2025 at 8:30 a.m. ET. A live webcast of the conference call, together with supplemental information, can be accessed through the Company's Investor Relations website at investors.quakerhoughton.com. You can also access the conference call by dialing 877-269-7756. 

    About Quaker Houghton

    Quaker Houghton is the global leader in industrial process fluids.  With a presence around the world, including operations in over 25 countries, our customers include thousands of the world's most advanced and specialized steel, aluminum, automotive, aerospace, offshore, container, mining, and metalworking companies. Our high-performing, innovative and sustainable solutions are backed by best-in-class technology, deep process knowledge and customized services. With approximately 4,400 employees, including chemists, engineers and industry experts, we partner with our customers to improve their operations so they can run even more efficiently, even more effectively, whatever comes next. Quaker Houghton is headquartered in Conshohocken, Pennsylvania, located near Philadelphia in the United States. Visit quakerhoughton.com to learn more. 

     

    Quaker Chemical Corporation

    Condensed Consolidated Statements of Operations

    (Unaudited; Dollars in thousands, except per share data)





    Three Months Ended

    June 30,



    Six Months Ended

    June 30,



    2025



    2024



    2025



    2024

    Net sales

    $         483,400



    $         463,567



    $         926,314



    $         933,326

    Cost of goods sold

    311,677



    287,849



    593,331



    576,045

    Gross profit

    171,723



    175,718



    332,983



    357,281

    Selling, general and administrative expenses

    126,600



    116,949



    245,646



    241,129

    Impairment charges

    88,840



    —



    88,840



    —

    Restructuring and related charges, net

    8,793



    320



    23,383



    2,177

    Operating (loss) income

    (52,510)



    58,449



    (24,886)



    113,975

    Other (expense) income, net

    (653)



    422



    (1,362)



    1,502

    Interest expense

    (12,779)



    (10,754)



    (22,324)



    (21,578)

    (Loss) income before taxes and equity in net income of associated companies

    (65,942)



    48,117



    (48,572)



    93,899

    Taxes on income before equity in net income of associated companies

    5,472



    15,778



    13,014



    28,286

    (Loss) income before equity in net income of associated companies

    (71,414)



    32,339



    (61,586)



    65,613

    Equity in net income of associated companies

    4,851



    2,571



    7,940



    4,555

    Net (loss) income

    (66,563)



    34,910



    (53,646)



    70,168

    Less: Net income attributable to noncontrolling interest

    17



    25



    12



    56

    Net (loss) income attributable to Quaker Chemical Corporation

    $          (66,580)



    $           34,885



    $          (53,658)



    $           70,112

    Per share data:















    Net (loss) income attributable to Quaker Chemical Corporation common shareholders – basic

    $              (3.78)



    $                1.94



    $              (3.04)



    $                3.90

    Net (loss) income attributable to Quaker Chemical Corporation common shareholders – diluted

    $              (3.78)



    $                1.94



    $              (3.04)



    $                3.89

    Basic weighted average common shares outstanding

    17,572,447



    17,921,395



    17,605,920



    17,915,104

    Diluted weighted average common shares outstanding

    17,592,971



    17,940,156



    17,630,541



    17,934,950

     

    Quaker Chemical Corporation

    Condensed Consolidated Balance Sheets

    (Unaudited; Dollars in thousands, except par value)





    June 30,

    2025



    December 31,

    2024

    ASSETS







    Current assets







    Cash and cash equivalents

    $          201,918



    $         188,880

    Accounts receivable, net

    437,411



    400,126

    Inventories

    264,347



    227,472

    Prepaid expenses and other current assets

    70,431



    59,939

    Total current assets

    974,107



    876,417









    Property, plant and equipment, net

    286,511



    229,532

    Right-of-use lease assets

    40,610



    34,120

    Goodwill

    502,438



    518,894

    Other intangible assets, net

    908,297



    827,098

    Investments in associated companies

    104,488



    98,012

    Deferred tax assets

    9,251



    9,216

    Other non-current assets

    23,108



    17,360

    Total assets

    $       2,848,810



    $      2,610,649









    LIABILITIES AND EQUITY







    Current liabilities







    Short-term borrowings and current portion of long-term debt

    $            37,867



    $           37,554

    Accounts payable

    203,606



    198,137

    Dividends payable

    8,436



    8,572

    Accrued compensation

    36,398



    50,212

    Accrued restructuring

    7,646



    2,297

    Accrued pension and postretirement benefits

    2,253



    2,328

    Other accrued liabilities

    83,853



    80,668

    Total current liabilities

    380,059



    379,768









    Long-term debt

    897,953



    669,614

    Long-term lease liabilities

    24,315



    20,028

    Deferred tax liabilities

    151,038



    138,828

    Non-current accrued pension and postretirement benefits

    24,491



    23,783

    Other non-current liabilities

    25,499



    24,445

    Total liabilities

    1,503,355



    1,256,466









    Equity







    Common stock $1 par value; authorized 30,000,000 shares; issued and outstanding

         June 30, 2025 – 17,394,128 shares; December 31, 2024 – 17,673,607 shares

    17,394



    17,674

    Capital in excess of par value

    876,969



    903,781

    Retained earnings

    563,063



    633,731

    Accumulated other comprehensive loss

    (115,181)



    (201,619)

    Total Quaker shareholders' equity

    1,342,245



    1,353,567

    Noncontrolling interest

    3,210



    616

    Total equity

    1,345,455



    1,354,183

    Total liabilities and equity

    $       2,848,810



    $      2,610,649

     

    Quaker Chemical Corporation

    Condensed Consolidated Statements of Cash Flows

    (Unaudited; Dollars in thousands)





    Six Months Ended

    June 30,



    2025



    2024

    Cash flows from operating activities







    Net (loss) income

    $          (53,646)



    $           70,168

    Adjustments to reconcile net income to net cash provided by operating activities:







    Depreciation and amortization

    44,278



    41,984

    Equity in undistributed earnings of associated companies, net of dividends

    (44)



    (4,221)

    Deferred income taxes

    $          (15,634)



    (3,728)

    Share-based compensation

    6,903



    8,128

    Impairment charges

    88,840



    —

    Restructuring and related charges, net

    23,383



    2,177

    Inventory step-up amortization

    6,022



    —

    Gain on disposal of property, plant, equipment and other assets

    (2,108)



    (509)

    Other adjustments

    (5,228)



    3,302

    Increase (decrease) in cash from changes in current assets and current liabilities, net of acquisitions:







    Accounts receivable

    3,022



    10,483

    Inventories

    (11,826)



    (9,141)

    Prepaid expenses and other current assets

    (3,943)



    (15,646)

    Accrued restructuring

    (15,946)



    (4,442)

    Accounts payable and accrued liabilities

    (25,551)



    (25,021)

    Net cash provided by operating activities

    38,522



    73,534

    Cash flows from investing activities







    Investments in property, plant and equipment

    (20,289)



    (11,124)

    Payments related to acquisitions, net of cash acquired

    (164,078)



    (24,899)

    Proceeds from disposition of assets

    2,950



    2,798

    Other investing activities

    697



    —

    Net cash used in investing activities

    (180,720)



    (33,225)

    Cash flows from financing activities







    Payments of long-term debt

    (17,205)



    (34,169)

    Borrowings on revolving credit facilities, net

    216,000



    20,533

    Payments on other debt, net

    (101)



    (37)

    Dividends paid

    (17,146)



    (16,372)

    Shares purchased under share repurchase programs

    (32,693)



    (7,760)

    Other stock related activity

    (1,301)



    (1,492)

    Net cash provided by financing activities

    147,554



    (39,297)

    Effect of foreign exchange rate changes on cash

    7,682



    (6,971)

    Net increase (decrease) in cash and cash equivalents

    13,038



    (5,959)

    Cash and cash equivalents at the beginning of the period

    188,880



    194,527

    Cash and cash equivalents at the end of the period

    $         201,918



    $         188,568

     

    Quaker Houghton (PRNewsfoto/Quaker Houghton)

     

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/quaker-houghton-announces-second-quarter-2025-results-302518970.html

    SOURCE Quaker Chemical Corporation

    Get the next $KWR alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $KWR

    DatePrice TargetRatingAnalyst
    6/9/2025$146.00Hold → Buy
    Jefferies
    1/7/2025$200.00 → $170.00Overweight → Neutral
    Piper Sandler
    5/16/2024$220.00Overweight
    Piper Sandler
    6/2/2023$250.00Buy
    Stifel
    10/25/2022$196.00Outperform
    RBC Capital Mkts
    1/18/2022$265.00Neutral → Buy
    Seaport Research Partners
    More analyst ratings

    $KWR
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    QUAKER HOUGHTON ANNOUNCES SECOND QUARTER 2025 RESULTS

    Q2'25 net sales of $483.4 million, an increase of 4% Y/YOrganic sales volumes increased 2% Y/Y driven by new business wins of approximately 5%Q2'25 net loss of $66.6 million and loss per diluted share of $3.78, which includes an $88.8 million impairment chargeQ2'25 non-GAAP net income of $30.0 million and non-GAAP earnings per diluted share of $1.71Delivered adjusted EBITDA and adjusted EBITDA margins of $75.5 million and 15.6%, respectively, in Q2'25Share repurchases totaled $32.7 million in Q2'25 and the Company raised its quarterly cash dividend by approximately 5%CONSHOHOCKEN, Pa., July 31, 2025 /PRNewswire/ -- Quaker Houghton ("the Company") (NYSE:KWR), the global leader in industrial p

    7/31/25 4:30:00 PM ET
    $KWR
    Major Chemicals
    Industrials

    Quaker Houghton Announces a 5% Increase in Cash Dividend

    CONSHOHOCKEN, Pa., July 30, 2025 /PRNewswire/ -- The Board of Directors of Quaker Houghton (NYSE:KWR) today declared a $0.508 per share quarterly cash dividend, an increase of 4.7% over the prior dividend.  The quarterly dividend is payable on October 31, 2025, to shareholders of record at the close of business on October 17, 2025. Joseph A. Berquist, Chief Executive Officer and President commented, "Today's dividend increase announcement reflects our confidence in the future of Quaker Houghton and our ability to continue to generate strong and consistent cash flow.  Quaker Houghton remains committed to growth and its balanced capital allocation strategy is aimed at creating shareholder valu

    7/30/25 4:30:00 PM ET
    $KWR
    Major Chemicals
    Industrials

    Quaker Houghton Announces Second Quarter 2025 Earnings and Investor Call

    CONSHOHOCKEN, Pa., July 17, 2025 /PRNewswire/ -- Quaker Houghton (NYSE:KWR) today announced the following schedule and contact information for its second quarter 2025 earnings release and investor call. Earnings Release:  Thursday, July 31, 2025 (after market close)Visit the investor relations portion of Quaker Houghton'swebsite at https://investors.quakerhoughton.com/ Teleconference:  Friday, August 1, 2025, at 8:30 a.m. (ET)Participate live by phone or listen to live audio webcast through the investor relations portion of Quaker Houghton's website at https://investors.quakerhoughton.com/ Dial-in Number:  +1-877-269-7756 (toll-free)+1-201-689-7817 (toll)Please call 5-10 minutes prior to the

    7/17/25 4:30:00 PM ET
    $KWR
    Major Chemicals
    Industrials

    $KWR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Quaker Chemical upgraded by Jefferies with a new price target

    Jefferies upgraded Quaker Chemical from Hold to Buy and set a new price target of $146.00

    6/9/25 7:44:36 AM ET
    $KWR
    Major Chemicals
    Industrials

    Quaker Chemical downgraded by Piper Sandler with a new price target

    Piper Sandler downgraded Quaker Chemical from Overweight to Neutral and set a new price target of $170.00 from $200.00 previously

    1/7/25 8:12:21 AM ET
    $KWR
    Major Chemicals
    Industrials

    Piper Sandler initiated coverage on Quaker Chemical with a new price target

    Piper Sandler initiated coverage of Quaker Chemical with a rating of Overweight and set a new price target of $220.00

    5/16/24 7:34:46 AM ET
    $KWR
    Major Chemicals
    Industrials

    $KWR
    SEC Filings

    View All

    SEC Form 10-Q filed by Quaker Houghton

    10-Q - QUAKER CHEMICAL CORP (0000081362) (Filer)

    7/31/25 4:42:37 PM ET
    $KWR
    Major Chemicals
    Industrials

    Quaker Houghton filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - QUAKER CHEMICAL CORP (0000081362) (Filer)

    7/31/25 4:35:20 PM ET
    $KWR
    Major Chemicals
    Industrials

    Quaker Houghton filed SEC Form 8-K: Leadership Update

    8-K - QUAKER CHEMICAL CORP (0000081362) (Filer)

    7/22/25 4:02:23 PM ET
    $KWR
    Major Chemicals
    Industrials

    $KWR
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    $KWR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CEO and President Berquist Joseph A bought $49,944 worth of shares (482 units at $103.62), increasing direct ownership by 4% to 12,243 units (SEC Form 4)

    4 - QUAKER CHEMICAL CORP (0000081362) (Issuer)

    5/13/25 4:17:17 PM ET
    $KWR
    Major Chemicals
    Industrials

    Gulf Hungary Holding Korlatolt Felelossegu Tarsasag sold 17,737 shares and bought 17,737 shares, decreasing direct ownership by 78% to 5,017 units (SEC Form 4)

    4 - QUAKER CHEMICAL CORP (0000081362) (Issuer)

    12/5/23 2:11:28 PM ET
    $KWR
    Major Chemicals
    Industrials

    Qh Hungary Holdings Ltd bought 17,737 shares, increasing direct ownership by 0.44% to 4,010,114 units (SEC Form 4)

    4 - QUAKER CHEMICAL CORP (0000081362) (Issuer)

    12/5/23 2:08:14 PM ET
    $KWR
    Major Chemicals
    Industrials

    New insider Dassing Steven R. claimed ownership of 157 shares (SEC Form 3)

    3 - QUAKER CHEMICAL CORP (0000081362) (Issuer)

    7/31/25 4:26:36 PM ET
    $KWR
    Major Chemicals
    Industrials

    Director West Fay converted options into 725 shares, increasing direct ownership by 22% to 4,063 units (SEC Form 4)

    4 - QUAKER CHEMICAL CORP (0000081362) (Issuer)

    6/3/25 4:42:59 PM ET
    $KWR
    Major Chemicals
    Industrials

    Director Shaller Russell converted options into 725 shares and was granted 551 shares, increasing direct ownership by 112% to 2,416 units (SEC Form 4)

    4 - QUAKER CHEMICAL CORP (0000081362) (Issuer)

    6/3/25 4:41:47 PM ET
    $KWR
    Major Chemicals
    Industrials

    $KWR
    Leadership Updates

    Live Leadership Updates

    View All

    Astronics Corporation Appoints Fay West to its Board of Directors

    Astronics Corporation (NASDAQ:ATRO), a leading provider of advanced technologies for global aerospace, defense and other mission critical industries, announced the appointment of Fay West to its Board of Directors, effective February 6, 2025. Ms. West brings over two decades of financial leadership experience across various industries. Since April 2021, she has served as Senior Vice President and Chief Financial Officer at Tennant Company (NYSE:TNC), a global leader in designing, manufacturing, and marketing solutions that help create a cleaner, safer, and healthier world. Peter J. Gundermann, Chairman, President and CEO, commented, "We are thrilled to welcome Fay to our Board of Director

    2/7/25 8:00:00 AM ET
    $ATRO
    $KWR
    $TNC
    Military/Government/Technical
    Industrials
    Major Chemicals
    Industrial Machinery/Components

    Quaker Houghton Appoints Joseph Berquist as CEO and President

    CONSHOHOCKEN, Pa., Nov. 18, 2024 /PRNewswire/ -- Quaker Houghton ((", the Company", , NYSE:KWR) announced today that its Board of Directors has appointed Joseph Berquist as Chief Executive Officer and President, and a member of the Board of Directors, effective immediately. Mr. Berquist, who succeeds Andy Tometich as Chief Executive Officer and President, most recently served as Executive Vice President and Chief Commercial Officer for Quaker Houghton. Michael F. Barry, Chairman of the Board of Directors of Quaker Houghton commented, "I want to thank Andy for his three years of leadership at Quaker Houghton. His outside perspective and experiences were valuable to help position the Company f

    11/18/24 4:30:00 PM ET
    $KWR
    Major Chemicals
    Industrials

    Quaker Houghton Appoints Two New Independent Directors to its Board of Directors

    CONSHOHOCKEN, Pa., July 31, 2024 /PRNewswire/ -- Quaker Houghton (NYSE:KWR) today announced the appointment of two new independent directors, Nandita Bakhshi and Lucrèce Foufopoulos-De Ridder, to the company's Board of Directors, effective immediately. Michael F. Barry, Chairman of the Board of Directors of Quaker Houghton, stated: "We are extremely pleased to welcome Nandita and Lucrèce to our Board.  They are both skilled global executives with extensive operational and strategic experience across a diverse set of global businesses and industries.  We are confident these proven leaders will make a meaningful contribution to our Board and the Company." Andy Tometich, Chief Executive Officer

    7/31/24 4:30:00 PM ET
    $KWR
    Major Chemicals
    Industrials

    $KWR
    Financials

    Live finance-specific insights

    View All

    QUAKER HOUGHTON ANNOUNCES SECOND QUARTER 2025 RESULTS

    Q2'25 net sales of $483.4 million, an increase of 4% Y/YOrganic sales volumes increased 2% Y/Y driven by new business wins of approximately 5%Q2'25 net loss of $66.6 million and loss per diluted share of $3.78, which includes an $88.8 million impairment chargeQ2'25 non-GAAP net income of $30.0 million and non-GAAP earnings per diluted share of $1.71Delivered adjusted EBITDA and adjusted EBITDA margins of $75.5 million and 15.6%, respectively, in Q2'25Share repurchases totaled $32.7 million in Q2'25 and the Company raised its quarterly cash dividend by approximately 5%CONSHOHOCKEN, Pa., July 31, 2025 /PRNewswire/ -- Quaker Houghton ("the Company") (NYSE:KWR), the global leader in industrial p

    7/31/25 4:30:00 PM ET
    $KWR
    Major Chemicals
    Industrials

    Quaker Houghton Announces a 5% Increase in Cash Dividend

    CONSHOHOCKEN, Pa., July 30, 2025 /PRNewswire/ -- The Board of Directors of Quaker Houghton (NYSE:KWR) today declared a $0.508 per share quarterly cash dividend, an increase of 4.7% over the prior dividend.  The quarterly dividend is payable on October 31, 2025, to shareholders of record at the close of business on October 17, 2025. Joseph A. Berquist, Chief Executive Officer and President commented, "Today's dividend increase announcement reflects our confidence in the future of Quaker Houghton and our ability to continue to generate strong and consistent cash flow.  Quaker Houghton remains committed to growth and its balanced capital allocation strategy is aimed at creating shareholder valu

    7/30/25 4:30:00 PM ET
    $KWR
    Major Chemicals
    Industrials

    Quaker Houghton Announces Second Quarter 2025 Earnings and Investor Call

    CONSHOHOCKEN, Pa., July 17, 2025 /PRNewswire/ -- Quaker Houghton (NYSE:KWR) today announced the following schedule and contact information for its second quarter 2025 earnings release and investor call. Earnings Release:  Thursday, July 31, 2025 (after market close)Visit the investor relations portion of Quaker Houghton'swebsite at https://investors.quakerhoughton.com/ Teleconference:  Friday, August 1, 2025, at 8:30 a.m. (ET)Participate live by phone or listen to live audio webcast through the investor relations portion of Quaker Houghton's website at https://investors.quakerhoughton.com/ Dial-in Number:  +1-877-269-7756 (toll-free)+1-201-689-7817 (toll)Please call 5-10 minutes prior to the

    7/17/25 4:30:00 PM ET
    $KWR
    Major Chemicals
    Industrials

    $KWR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Quaker Houghton

    SC 13D/A - QUAKER CHEMICAL CORP (0000081362) (Subject)

    12/17/24 4:18:46 PM ET
    $KWR
    Major Chemicals
    Industrials

    Amendment: SEC Form SC 13D/A filed by Quaker Houghton

    SC 13D/A - QUAKER CHEMICAL CORP (0000081362) (Subject)

    12/12/24 4:59:11 PM ET
    $KWR
    Major Chemicals
    Industrials

    Amendment: SEC Form SC 13D/A filed by Quaker Houghton

    SC 13D/A - QUAKER CHEMICAL CORP (0000081362) (Subject)

    12/9/24 4:07:20 PM ET
    $KWR
    Major Chemicals
    Industrials